Global X Genomics & Biotechnology ETF (NQ:GNOM)

56.65 -1.89 (-3.22%)

Official Closing Price Updated: 4:15 PM EDT, Jul 10, 2026 Add to My Watchlist

Price and Volume

Volume	33,559
Open	58.74
Bid (Size)	55.00 (300)
Ask (Size)	65.00 (900)
Prev. Close	58.54
Today's Range	56.02 - 58.74
52wk Range	34.04 - 59.48
Shares Outstanding	33,418,720
Dividend Yield	0.20%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Why Is CRSP Stock Falling Pre-Market Today? ↗

March 10, 2026

The company plans to issue $350 million in convertible senior notes that are scheduled to mature in 2031.

Via Stocktwits

Why Did BNTX Stock Tumble 17% Pre-Market Today? ↗

March 10, 2026

BioNTech co-founders Ugur Sahin and Özlem Türeci are set to leave the company to head the new venture.

Via Stocktwits

Performance

YTD	+24.1%	+24.1%
1 Month	+18.2%	+18.2%
3 Month	+29.0%	+29.0%
6 Month	+19.6%	+19.6%
1 Year	+57.0%	+57.0%

More News

Moderna Stock Gains After FDA Accepts Company’s Revised Flu Vaccine Application For Review ↗

February 18, 2026

Via Stocktwits

Qiagen Shares Rise Premarket As Preliminary Q1 Results, Hikes FY25 EPS Guidance ↗

April 07, 2025

Via Benzinga

ETF Battles ARKG Vs. GNOM - What's The Better Genomic/Biotech Play? ↗

June 04, 2021

Via Talk Markets

3 Gene Editing Stocks with Potential to Transform Medicine ↗

August 09, 2024

Via InvestorPlace

The 3 Best Gene Editing Stocks to Buy in July 2024 ↗

July 08, 2024

Via InvestorPlace

Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life ↗

May 10, 2024

Via InvestorPlace

3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire ↗

May 02, 2024

Via InvestorPlace

3 Stocks That Could Be the Next Big Thing in Gene Editing ↗

March 21, 2024

Via InvestorPlace

3 Gene Editing Stocks With Unprecedented Surge Potential ↗

February 13, 2024

Via InvestorPlace

3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential ↗

January 31, 2024

Via InvestorPlace

3 Gene Editing Stocks to Generate Super-Charged Gains ↗

October 18, 2023

Via InvestorPlace

The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket ↗

March 25, 2023

Via InvestorPlace

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗

March 15, 2023

Via InvestorPlace

3 Gene Editing Stocks With the Best Long-Term Potential ↗

January 25, 2023

Via InvestorPlace

3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years ↗

January 18, 2023

Via InvestorPlace

ETF Battles: Finding the Top Genomics Biotech ETF – A Triple Header of ARKG vs IDNA vs GNOM ↗

October 21, 2021

Via Talk Markets

A Comprehensive Guide To Genomic ETFs ↗

July 11, 2021

Via Talk Markets

Top-Performing Biotech ETFs of Last Week ↗

June 14, 2021

Via Talk Markets

Frequently Asked Questions

Is Global X Genomics & Biotechnology ETF publicly traded?

Yes, Global X Genomics & Biotechnology ETF is publicly traded.

What exchange does Global X Genomics & Biotechnology ETF trade on?

Global X Genomics & Biotechnology ETF trades on the Nasdaq Stock Market

What is the ticker symbol for Global X Genomics & Biotechnology ETF?

The ticker symbol for Global X Genomics & Biotechnology ETF is GNOM on the Nasdaq Stock Market

What is the current price of Global X Genomics & Biotechnology ETF?

The current price of Global X Genomics & Biotechnology ETF is 56.65

When was Global X Genomics & Biotechnology ETF last traded?

The last trade of Global X Genomics & Biotechnology ETF was at 07/10/26 04:15 PM ET

What is the market capitalization of Global X Genomics & Biotechnology ETF?

The market capitalization of Global X Genomics & Biotechnology ETF is 1.89B

How many shares of Global X Genomics & Biotechnology ETF are outstanding?

Global X Genomics & Biotechnology ETF has 2B shares outstanding.